M Pharmaceutical Inc Share Price Deutsche Boerse AG
Equities
CA55346E2050
Biotechnology & Medical Research
Sales 2018 | 0.75 0.69 59.08 | Sales 2019 | 0.71 0.66 55.86 | Capitalization | 3.53M 3.26M 278M |
---|---|---|---|---|---|
Net income 2018 | -5M -4.62M -394M | Net income 2019 | -1M -925K -78.77M | EV / Sales 2018 | 4,852,616 x |
Net Debt 2018 | 319K 295K 25.13M | Net Debt 2019 | 848K 784K 66.77M | EV / Sales 2019 | 6,168,166 x |
P/E ratio 2018 |
-0.6
x | P/E ratio 2019 |
-1.97
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 72.04% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 02/01/18 | |
Robert Payment
DFI | Director of Finance/CFO | 42 | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Skeith
BRD | Director/Board Member | 69 | 30/11/14 |
William Rodgers
BRD | Director/Board Member | - | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
1st Jan change | Capi. | |
---|---|---|
+64.92% | 62.59B | |
-1.85% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.05% | 26.21B | |
-21.96% | 19.09B | |
+4.21% | 13.08B | |
+25.74% | 12.26B | |
+27.42% | 12.05B |